Synergy in nutrients

Alternative and Complementary Therapies

Volumn 10, Issue 6, 2004, Pages 326-329

  Meletis, Chris D ^a,b   Barker, Jason E ^c  

^a Wellness Matters   (United States)

^b National College of Natural Medicine   (United States)

^c Healthmax   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CARNITINE; CHOLINE; FLAVONOID; GLYCINE SOJA EXTRACT; MAGNESIUM; MALPIGHIA GLABRA EXTRACT; MEDICAGO SATIVA EXTRACT; PHOSPHATIDYLCHOLINE; PLANT EXTRACT; UBIDECARENONE; UNCLASSIFIED DRUG; VACCINIUM MYRTILLUS EXTRACT; VITAMIN B GROUP; VITIS VINIFERA EXTRACT;

BIOSYNTHESIS; BRAIN DISEASE; CHOLESTEROL BLOOD LEVEL; CONGESTIVE CARDIOMYOPATHY; CONNECTIVE TISSUE DISEASE; DRUG EFFECT; ENZYME SYNTHESIS; FOLLOW UP; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTROPHY; ISCHEMIC HEART DISEASE; KIDNEY CLEARANCE; MUSCLE DISEASE; NONHUMAN; NUTRIENT; REPERFUSION INJURY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

EID: 10644263487     PISSN: 10762809     EISSN: None     Source Type: Journal    
DOI: 10.1089/act.2004.10.326     Document Type: Review

References (35)

1. Greenberg S, Fishman WH. Coenzyme Q10: A new drug for cardiovascular disease. J Clin Pharmacol 1990;30:596-608.
2. Pizzorno JE Jr, Murray M. Textbook of Natural Medicine, 2nd ed. New York: Churchill Livingstone, 1999.
3. Evans A, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003;42:941-967.
4. Cacciatore L, Cerio R, Ciarimboli M, et al. The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: A controlled study. Drugs Exp Clin Res 1991;17:225-235.
5. Sole MJ, Jeejeebhoy KN. Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr Opin Clin Nutr Metab Care 2000;3:417-424.
6. Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am Heart J 2000;139 (2pt3):S120-S123.
7. Carvajal K, Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res 2003;34:89-99.
8. Bertelli A, Ronca G. Carnitine and coenzyme Q10: Biochemical properties and functions, synergism and complementary action. Int J Tissue React 1990;12:183-186.
9. Bertelli A, Ronca F, Ronca G, Palmieri L, Zucchi R. L-Carnitine and coenzyme Q10 protective action against ischaemia and reperfusion of working rat heart. Drugs Exp Clin Res 1992;18:431-436.
10. Beal MF. Bioenergetic approaches for neuroprotection in Parkinson's disease. Ann Neurol 2003;53(suppl3)S39-S47;discussion S47-S48.
11. Feher J, Papale A, Mannino G, Gualdi L, Balacco Gabrieli C. Mitotropic compounds for the treatment of age-related macular degeneration: The metabolic approach and a pilot study. Ophthalmologica 2003;217:351-357.
12. Zeisel SH. Choline: Needed for normal development of memory. J Am Coll Nutr 2000;19(5suppl):528S-531S.
13. Brook JG, Linn S, Aviram M. Dietary soya lecithin decreases plama triglyceride levels and inhibits collagen- and ADP-induced platelet aggregation. Biochem Med Metabol Biol 1986;35:31-39.
14. Wojcicki J. Clinical evaluation of lecithin as a lipid-lowering agent. Phytotherapy Res 1995;9:597-599.
15. Dodson WL, Sachan DS. Choline supplementation reduces urinary carnitine excretion in humans. Am J Clin Nutr 1996;63:904-910.
16. Daily JW 3rd, Sachan DS. Choline supplementation alters carnitine homeostasis in humans and guinea pigs. J Nutr 1995;125:1938-1944.
17. Rebouche CJ. Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr 1991;54(6suppl):1147S-1152S.
18. Otsuka M, Matsuzawa M, Ha TY, Arakawa N. Contribution of a high dose of L-ascorbic acid to carnitine synthesis in guinea pigs fed high-fat diets. J Nutr Sci Vitaminol (Tokyo) 1999;45:163-171.
19. Ha TY, Otsuka M, Arakawa N. Ascorbate indirectly stimulates fatty acid utilization in primary cultured guinea pig hepatocytes by enhancing carnitine synthesis. J Nutr 1994;124:732-737.
20. Akar H, Sarac A, Konuralp C, Yildiz L, Kolbakir F. Comparison of histopathologic effects of carnitine and ascorbic acid on reperfusion injury. Eur J Cardiothorac Surg 2001;19:500-506.
21. Johnston CS, Solomon RE, Corte C. Vitamin C depletion is associated with alterations in blood histamine and plasma free carnitine in adults. J Am Coll Nutr 1996;15:586-591.
22. Henriet JP. Veno-lymphatic insufficiency: 4,729 patients undergoing hormonal and procyanidol oligomer therapy. Phlebologie 1993;46:313-325.
23. Bagchi D, Sen CK, Ray SD, Das DK, Bagchi M, Preuss HG, Vinson JA. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003;523-524:87-97.
24. Peirce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: William Morrow and Co., 1999.
25. Harvsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-1148.
26. Bottecchia D, et al. Preliminary reports on the inhibitory effect of Vaccinium myrtillus anthocyanosides on platelet aggregation and clot retraction. Fitoterapia 1987;48:3-8.
27. Kadar A, Robert L, Miskulin M, Tixier JM, Brechemier D, Robert AM. Influence of anthocyanoside treatment on the cholesterol-induced atherosclerosis in the rabbit. Paroi Arterielle 1979;5:187-205.
28. Vinson JA, Bose P. Comparative bioavailability to humans of ascorbic acid alone or in a citrus extract. Am J Clin Nutr 1988;48:601-604.
29. Hwang J, Hodis HN, Sevanian A. Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem 2001;49:308-314.
30. Appel LJ. Nonpharmacologic therapies that reduce blood pressure: A fresh perspective. Clin Cardiol 1999;22:1111-1115.
31. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academy Press, 1999.
32. Ford ES. Serum magnesium and ischaemic heart disease: Findings from a national sample of U.S. adults. Intl J Epidemiol 1999;28:645-651.
33. Resnick LM. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: A unifying theme. J Am Soc Nephrol 1992;3(4suppl):S78-S85.
34. 6 status in the rat. J Am Coll Nutr 1997;16:352-356.
35. 12 and folate on homocysteinemia-induced depletion of intracellular free magnesium ions in canine cerebral vascular smooth muscle cells: Possible relationship to [Ca2+]i, atherogenesis and stroke. Neurosci Lett 1999;274:83-86.